Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial

Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial

Introduction: The benefit of surfactant prescription for respiratory distress syndrome (RDS) has been approved. Curosurf and Survanta are two commonly used natural surfactants in Iran. Previous studies did not report priority for one of these two drugs. The present study aimed to compare the effecti...

Full description

Bibliographic Details
Main Authors: Bita Najafian, Hamidreza Karimi-Sari, Mohammad Hossein Khosravi, Niloofar Nikjoo, Sobhan Amin, Majid Shohrati
Format: Article
Language:English
Published: Elsevier 2016-08-01
Series:Contemporary Clinical Trials Communications
Subjects:
Respiratory distress syndrome
Beractant
Poractant alfa
Complications
Treatment outcome
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865415300181

Internet

http://www.sciencedirect.com/science/article/pii/S2451865415300181

Similar Items